Duquesne Family Office 13F, Q1 2025

Stanley Druckenmiller · quarter ending 31 March 2025 · filed 15 May 2025 · SEC CIK 1536411

$2.98B
Filed US book
49
Positions
16.1%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed. The filing also lists 3 put and call lines, reported at the value of the underlying shares; they are not ownership and are not in these totals.

Largest positions, Q1 2025

The 25 largest of 49 positions. Weights are against the whole filed book. Changes are in shares held, against the Q4 2024 filing.

CompanyTickerValue% of bookvs Q4 2024
Natera IncNTRA$481.12M16.1%-5% shares
Teva Pharmaceutical Inds LtdTEVA$228.70M7.7%+65% shares
Coupang IncCPNG$204.01M6.8%+5% shares
Woodward IncWWD$200.33M6.7%-10% shares
Philip Morris Intl IncPM$175.44M5.9%-18% shares
Coherent CorpCOHR$144.30M4.8%-21% shares
Mercadolibre IncMELI$104.81M3.5%unchanged
Insmed IncINSM$104.44M3.5%+131% shares
Taiwan Semiconductor Mfg LtdTSM$99.40M3.3%+457% shares
Docusign IncDOCU$87.48M2.9%new
Flutter Entmt Plc$83.57M2.8%+1986% shares
Eli Lilly & CoLLY$78.32M2.6%+53% shares
Ypf Sociedad AnonimaYPF$72.72M2.4%+23% shares
Verona Pharma Plc$63.62M2.1%+13% shares
Barclays PlcBCS$58.63M2.0%+20% shares
WabtecWAB$54.60M1.8%+8% shares
Ccc Intelligent Solutions HlCCC$50.52M1.7%new
Kinder Morgan Inc DelKMI$47.19M1.6%-26% shares
Eqt CorpEQT$45.91M1.5%new
Caesars Entertainment Inc NeCZR$38.71M1.3%new
Freeport-Mcmoran IncFCX$38.55M1.3%+34% shares
Daktronics IncDAKT$37.36M1.3%+17% shares
Global X FdsARGT$35.85M1.2%-19% shares
Twilio IncTWLO$35.46M1.2%new
Capital One Finl CorpCOF$35.44M1.2%new

What changed since Q4 2024

Against the Q4 2024 filing, Duquesne Family Office opened 12 new positions, added to 14, trimmed 17, left 6 unchanged and exited 37. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

and 4 more

Exited

  • Skechers U S A Incwas $72.27M
  • SLMwas $69.51M
  • United States Stl Corpwas $54.73M
  • WBDwas $49.23M
  • VSTwas $39.07M
  • MUwas $34.41M
  • KREwas $33.44M
  • BWXTwas $33.33M

and 29 more

Added to

  • TEVA+65%$228.70M
  • CPNG+5%$204.01M
  • INSM+131%$104.44M
  • TSM+457%$99.40M
  • Flutter Entmt Plc+1986%$83.57M
  • LLY+53%$78.32M
  • YPF+23%$72.72M
  • Verona Pharma Plc+13%$63.62M

and 6 more

Trimmed

  • NTRA-5%$481.12M
  • WWD-10%$200.33M
  • PM-18%$175.44M
  • COHR-21%$144.30M
  • KMI-26%$47.19M
  • ARGT-19%$35.85M
  • BMA-11%$32.61M
  • Springworks Therapeutics Inc-28%$27.18M

and 9 more

Other quarters

Source: SEC Form 13F-HR, accession 0001536411-25-000008, filed by Duquesne Family Office LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.